欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
https://www.in-pharmatechnologist.com/Article/2018/02/05/Fake-meds-on-trial-EU-report-weighs-up-Member-State-punishment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSSEU
报告要求成员国统一并严惩对假药的处罚力度,这里的Fake Meds包括制剂,原料药和辅料
Fake meds on trial: EU report weighs up Member State punishment
By Flora Southey 05-Feb-2018 - Last updated on 05-Feb-2018 at 14:55 GMT

GettyImages/stormwatch153
Diverging penalties in EU Member States for the falsification of medicines raise concerns for organised crime, says Medicines for Europe.
The European Commission (EC) has submitted a report detailing the application of penalties for those involved in the production and circulation of falsified medicines to the European Parliament on the request of the Falsified Medicines Directive (2011/62/EU)​. Article 118a of the Directive calls on EU Member States to adopt “effective, proportionate and dissuasive” ​penalties regarding the “ manufacturing, distribution, brokering, import and export of falsified medicinal products”,​ as well as active substances and excipients. A call for strict enforcement​While the Commission said measures taken by Member States are “satisfactory”​, it has called for their strict enforcement. “…penalties are only effective if they are well-enforced,” ​said commissioner for health and food safety Vytenis Andriukaitis, adding: “I urge all EU countries to make sure that criminals falsifying medicines are punished.”​ “I seize the opportunity to remind that thanks to the common ​EU logo​​ which helps identify legal online pharmacies that sell authentic and safe products, citizens can be helped to steer clear of falsified medicines,” ​he said. Medicines for Europe’s concern​Medicines for Europe similarly highlighted the need for Member State cooperation. The pharmaceutical association “considers the falsification of medicines not as a petty crime, but as a severe criminal activity which can lead to death of patients as a consequence,” ​market access director Maarten van Baelen told us. We are “grateful for actions taken by Interpol, Europol, police, customs, health regulatory authorieis and others who are involved in actions to fight the sales of illicit medicines,” ​he added. However, van Baelen expressed concern regarding the diverging levels of fees in the different countries. “Maximum fines range from 4,300 in Lithuania to
|